Clinical Trial Update: The Effect of Aprepitant Reducing Postoperative Nausea and Vomiting [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating whether aprepitant reduces postoperative nausea and vomiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Postoperative Nausea and Vomiting

Drugs mentioned

• Aprepitant (aprepitant)

Snippet

Sponsor: Hospital General Tlahuac | Conditions: Obesity, Nausea and Vomiting, Postoperative | Phase 4 | Status: UNKNOWN